These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31531455)

  • 1. Total synthesis of verucopeptin, an inhibitor of hypoxia-inducible factor 1 (HIF-1).
    Takahashi N; Hayashi H; Poznaks V; Kakeya H
    Chem Commun (Camb); 2019 Oct; 55(79):11956-11959. PubMed ID: 31531455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure Elucidation of Verucopeptin, a HIF-1 Inhibitory Polyketide-Hexapeptide Hybrid Metabolite from an Actinomycete.
    Yoshimura A; Nishimura S; Otsuka S; Hattori A; Kakeya H
    Org Lett; 2015 Nov; 17(21):5364-7. PubMed ID: 26484856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total synthesis of odoamide, a novel cyclic depsipeptide, from an Okinawan marine cyanobacterium.
    Kaneda M; Sueyoshi K; Teruya T; Ohno H; Fujii N; Oishi S
    Org Biomol Chem; 2016 Sep; 14(38):9093-9104. PubMed ID: 27722687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total Synthesis and Stereochemical Revision of Stereocalpin A: Mirror-Image Approach for Stereochemical Assignments of the Peptide-Polyketide Macrocycle.
    Kaneda M; Inuki S; Ohno H; Oishi S
    J Org Chem; 2018 Mar; 83(6):3047-3060. PubMed ID: 29470088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, Synthesis, and Conformation-Activity Study of Unnatural Bridged Bicyclic Depsipeptides as Highly Potent Hypoxia Inducible Factor-1 Inhibitors and Antitumor Agents.
    Koike K; Nagano M; Ebihara M; Hirayama T; Tsuji M; Suga H; Nagasawa H
    J Med Chem; 2020 Apr; 63(8):4022-4046. PubMed ID: 32202785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction and determination of the stereochemistry of the 1,3,5-trimethyl-substituted alkyl chain in verucopeptin, a microbial metabolite.
    Yoshimura A; Kishimoto S; Nishimura S; Otsuka S; Sakai Y; Hattori A; Kakeya H
    J Org Chem; 2014 Aug; 79(15):6858-67. PubMed ID: 25014229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of neolamellarin A, an inhibitor of hypoxia-inducible factor-1.
    Arafeh KM; Ullah N
    Nat Prod Commun; 2009 Jul; 4(7):925-6. PubMed ID: 19731594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and structure-activity relationships of 1-ethylpyrazole-3-carboxamide compounds as novel hypoxia-inducible factor (HIF)-1 inhibitors.
    Yasuda Y; Arakawa T; Nawata Y; Shimada S; Oishi S; Fujii N; Nishimura S; Hattori A; Kakeya H
    Bioorg Med Chem; 2015 Apr; 23(8):1776-87. PubMed ID: 25773014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Late-Stage Modification of (-)-Doliculide Derivatives Using Matteson's Homologation Approach.
    Tost M; Kazmaier U
    Mar Drugs; 2024 Apr; 22(4):. PubMed ID: 38667782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity relationships of novel, potent, orally active hypoxia-inducible factor-1 inhibitors.
    Nagao S; Yamane Y; Funasaka S; Tanaka K; Miyazaki K; Kotake Y; Kamata J; Watanabe-Miyano S; Toyama O; Ozawa Y; Mizui Y; Okamoto K; Ito D
    Bioorg Med Chem; 2014 Oct; 22(19):5513-29. PubMed ID: 25139751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolactonization of peptide thioesters catalyzed by imidazole and its application in the synthesis of kahalalide B and analogues.
    Li Y; Giulionatti M; Houghten RA
    Org Lett; 2010 May; 12(10):2250-3. PubMed ID: 20426464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The depsipeptide technique applied to peptide segment condensation: scope and limitations.
    Coin I; Schmieder P; Bienert M; Beyermann M
    J Pept Sci; 2008 Mar; 14(3):299-306. PubMed ID: 17935259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total synthesis and assignment of the side chain stereochemistry of LI-F04a: an antimicrobial cyclic depsipeptide.
    Cochrane JR; McErlean CS; Jolliffe KA
    Org Lett; 2010 Aug; 12(15):3394-7. PubMed ID: 20608662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A general solid phase method for the synthesis of depsipeptides.
    Nguyen MM; Ong N; Suggs L
    Org Biomol Chem; 2013 Feb; 11(7):1167-70. PubMed ID: 23306773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quassinoid 6alpha-tigloyloxychaparrinone inhibits hypoxia-inducible factor-1 pathway by inhibition of eukaryotic translation initiation factor 4E phosphorylation.
    Jin X; Jin HR; Lee D; Lee JH; Kim SK; Lee JJ
    Eur J Pharmacol; 2008 Sep; 592(1-3):41-7. PubMed ID: 18639543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total synthesis and stereochemical assignment of burkholdac B, a depsipeptide HDAC inhibitor.
    Benelkebir H; Donlevy AM; Packham G; Ganesan A
    Org Lett; 2011 Dec; 13(24):6334-7. PubMed ID: 22091906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total synthesis of halipeptin A: a potent antiinflammatory cyclic depsipeptide.
    Yu S; Pan X; Lin X; Ma D
    Angew Chem Int Ed Engl; 2004 Dec; 44(1):135-8. PubMed ID: 15599918
    [No Abstract]   [Full Text] [Related]  

  • 18. Asymmetric Synthesis of the C15⁻C32 Fragment of Alotamide and Determination of the Relative Stereochemistry.
    Shi HY; Xie Y; Hu P; Guo ZQ; Lu YH; Gao Y; Huang CG
    Mar Drugs; 2018 Oct; 16(11):. PubMed ID: 30380702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse synthesis of marine cyclic depsipeptide lagunamide A and its analogues.
    Huang W; Ren RG; Dong HQ; Wei BG; Lin GQ
    J Org Chem; 2013 Nov; 78(21):10747-62. PubMed ID: 24090274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total synthesis and cytotoxicity studies of a cyclic depsipeptide with proposed structure of palau'amide.
    Zou B; Long K; Ma D
    Org Lett; 2005 Sep; 7(19):4237-40. PubMed ID: 16146396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.